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Purpose:

To extend a commonly used noninvasive arterial spin labeling magnetic resonance (MR) imaging method for measuring blood flow to evaluate lymphatic flow.

Materials and
Methods:

All volunteers (n = 12) provided informed consent in accordance with institutional review board and HIPAA regulations. Quantitative relaxation time (T1 and T2) measurements were made in extracted human lymphatic fluid
at 3.0 T. Guided by these parameters, an arterial spin
labeling MR imaging approach was adapted to measure
lymphatic flow (flow-alternating inversion-recovery lymphatic water labeling, 3 3 3 3 5 mm) in healthy subjects
(n = 6; mean age, 30 years 6 1 [standard deviation]; recruitment duration, 2 months). Lymphatic flow velocity
was quantified by performing spin labeling measurements
as a function of postlabeling delay time and by measuring time to peak signal intensity in axillary lymph nodes.
Clinical feasibility was evaluated in patients with stage II
lymphedema (three women; age range, 43–64 years) and
in control subjects with unilateral cuff-induced lymphatic
stenosis (one woman, two men; age range, 31–35 years).

Results:

Mean T1 and T2 relaxation times of lymphatic fluid at 3.0
T were 3100 msec 6 160 (range, 2930–3210 msec; median,
3200 msec) and 610 msec 6 12 (range, 598–618 msec; median, 610 msec), respectively. Healthy lymphatic flow (afferent vessel to axillary node) velocity was 0.61 cm/min 6 0.13
(n = 6). A reduction (P , .005) in lymphatic flow velocity in
the affected arms of patients and the affected arms of healthy
subjects with manipulated cuff-induced flow reduction was
observed. The ratio of unaffected to affected axilla lymphatic
velocity (1.24 6 0.18) was significantly (P , .005) higher
than the left-to-right ratio in healthy subjects (0.91 6 0.18).

Conclusion:

This work provides a foundation for clinical investigations
whereby lymphedema etiogenesis and therapies may be
interrogated without exogenous agents and with clinically
available imaging equipment.
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reast cancer treatment–related
lymphedema is characterized by
chronic incurable swelling of the
arm and occasionally the trunk after
axillary lymph node dissection and represents a major health concern in developed nations (1). Of approximately
2.3 million breast cancer survivors in
the United States, 19%–49% of patients
who undergo axillary lymph node dissection and radiation therapy develop
lymphedema (2–4). Identification of
subclinical lymphedema has shown that
only 7% of patients who receive structured physical therapy develop lymphedema in the 1st year, relative to 25%
of control subjects who do not receive
physical therapy (5). Thus, early identification of patients at high risk for lymphedema is critical; however, cost-effective
screening that does not require specialized equipment is required for widespread implementation (6).
Recently, lymphatic contractility and
pumping have been measured by using
technetium 99m nuclear imaging, which
has shown that reduction in lymphatic
velocity is proportional to the severity of
swelling and that intersubject variability

Advances in Knowledge
nn Quantitative longitudinal (T1)
and transverse (T2) relaxation
time measurements of human
lymphatic fluid are presented at
3.0 T.
nn Feasibility of noninvasive assessment of lymphatic flow velocities
by using principles of spin labeling is shown, analogous to the
popular arterial spin labeling
method used to quantify
perfusion.
nn Expected reductions in lymphatic
flow velocity are found both in
healthy individuals under conditions of manipulated lymphatic
flow obstruction and in patients
with stage II lymphedema.
nn A kinetic model for lymphatic
spin labeling measurements is
introduced, and it can be used to
quantitatively understand sources
of variability in patients.
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in lymphatic pump failure may contribute to lymphedema risk (7). However,
routine clinical implementation of comparable computed tomographic (CT)
(8,9), optical (10), and magnetic resonance (MR) lymphangiographic (11)
techniques is complicated by requirements for ionizing radiation, specialized
optical probes and fluorophores, and/or
exogenous contrast agents, respectively
(6). Thus, radiologic screening could
greatly benefit from procedures that
yield comparable information but are
easier to implement.
MR imaging has been widely used to
evaluate fluid transportation in several
contexts; however, noninvasive MR imaging techniques with which to assess
lymphatic flow remain underdeveloped.
Importantly, to our knowledge, even basic measurements of relaxation times
of human lymphatic fluid (T1 and T2)
at current imaging fields have not been
published, thereby precluding rigorous
quantification of lymphatic contrast.
However, the principles of lymphatic
flow are analogous to those of blood and
cerebrospinal fluid flow, two physiologic
phenomena that have been measured
successfully with MR imaging for more
than 2 decades (12–14). The lymphatic
system is unidirectional and open ended;
lymphatic fluid is carried to lymph nodes
via lymphatic collectors through forces
supplied by smooth muscle contractions.
Thus, noninvasive arterial spin labeling
MR imaging approaches commonly used
to magnetically label blood water and

quantify blood flow and tissue perfusion
and that have been used clinically in
oncology (15), cerebrovascular disease
(16–18), and cognitive neuroimaging
(19,20) should translate to lymphatic
imaging. The major obstacles include
(a) slower velocity of lymph relative to
blood and (b) increased field heterogeneity and radiofrequency (RF) labeling
inefficiency in the extremities. We hypothesize that these difficulties can be
alleviated (a) because of the longer lymphatic water T1 relaxation time relative
to the blood water T1 relaxation time
and (b) by applying new hardware advances, including multichannel receive
coils in conjunction with parallel RF
transmit technology, to detect and label
lymphatic water over small regions with
high efficiency.
The purpose of this study was to extend a commonly used noninvasive arterial spin labeling MR imaging method
for measuring blood flow to evaluate
lymphatic flow.

Materials and Methods
This study was approved by the Vanderbilt University institutional review
board. All patients and healthy subjects
provided informed written consent.
Approximately 200 mL of lymphatic
fluid was acquired at three different
dates and times in a 16-year-old female
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nn An MR imaging method capable
of quantifying lymphatic flow velocities without exogenous contrast agent administration is presented; this method can be
readily implemented with commercially available MR imagers
and enables noninvasive assessment of lymphatic flow in vivo,
which should be useful in the
identification of disease biomarkers or the evaluation of
therapies in patients with postbreast cancer–related
lymphedema.
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patient with a congenital deep lymphatic
impairment that required an abdominal
lymphatic shunt to permit self-drainage
of lymphatic fluid collection. The fluid
was immediately transferred to a sterile container, deidentified, maintained
at physiologic temperature, and transported to the imaging facility. Because
the lymph sample typically would have
been discarded as waste and because
this sample was deidentified before it
was brought to the imaging institute,
the institutional review board determined this aspect of the study did not
qualify as human subject research. The
study was in compliance with Health
Insurance Portability and Accountability Act regulations.

Relaxation Time Measurements
Lymphatic fluid experiments were conducted within approximately 30 minutes
of fluid extraction with a Philips 3.0-T
MR imager (Achieva; Philips Medical
Systems, Best, the Netherlands). The
fluid sample was maintained at body
temperature by using a warm water
bath throughout imaging. A thermochromic thermometer (Apothecary
Products, Minneapolis, Minn) was used
to monitor sample temperature.
T1 measurement.—Images were
acquired at different inversion times
(range, 0–10 000 msec at an interval of
500 msec), as well as with a long inversion time (20 sec) for equilibrium
magnetization calibration. Other parameters were as follows: repetition
time msec/echo time msec, 40 000/28;
spatial resolution, 3 3 3 3 5 mm; and
single-shot echo-planar imaging, with
16-msec hyperbolic secant adiabatic
inversion prepulse. Inversion pulse duration and B1 were optimized for efficiency prior to T1 measurements. T1
was calculated by using a three-point
fit of the magnitude signal (S) and the
equation
S ( TI) = S0 {1 + [cos (θ ) −1] ⋅ e−TI/T1 } [1],

where S0 is the equilibrium signal intensity, S(TI) is the magnitude signal intensity, TI is the inversion time, and u is
the inversion angle. To confirm that T1
Radiology: Volume 269: Number 3—December 2013
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of the lymphatic fluid samples was representative of lymphatic water T1 in the
axilla, an inversion recovery experiment
was performed in a healthy volunteer.
We chose the inversion time such that
Mz(TI)/M0 = (122e2TI/T1+e2TR/T1) = 0,
where Mz is the longitudinal magnetization along the z axis, M0 is the steady
state magnetization, T1 was measured
lymphatic water T1, and repetition time
was 4 seconds. Signal-to-noise ratio measurements were made for images with
(denoted as nulled) and without (denoted as not nulled) the inversion prepulse
and were compared with measurements
in a free-form region of noise (160 voxels) within the surrounding lung cavity.
Thus, this is similar to a fluid-attenuated
inversion recovery experiment but with
the inversion time chosen to correspond
to the presumed lymphatic water Mz null
point rather than the cerebrospinal fluid
Mz null point.
T2 measurement.—Eight images,
each obtained with a different echo
time, were acquired with a multiecho spin-echo echo-planar imaging
sequence. Data were oversampled during the period of maximal signal decay,
yielding echo time points at 50, 150,
250, 350, 600, 1000, and 1400 msec.
Other parameters included repetition
time of 2500 msec and spatial resolution of 3 3 3 3 5 mm. T2 was quantified by using the monoexponential
equation:
S = S0e− TE T2 [2].

For the first sample, the range of echo
times was still under optimization and
was too low (0–200 msec) to enable accurate T2 measurement. Thus, only the
second and third samples were used for
T2 calculations.

Spin Labeling Measurements in
Unobstructed Lymphatic System
The idea for spin labeling MR imaging
is to acquire two sets of images, one
with and one without magnetic labeling
of inflowing water. After the labeling
prepulse, an inversion time is allowed
(generally 1–2 sec), which describes
the amount of time after labeling and
before acquisition. By comparing the

radiology.rsna.org
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difference in image contrast between
labeled and unlabeled images, a flowweighted image can be obtained. For
perfusion, the difference in image signal is small at only 1%–2% of tissue
signal; this signal arises from the small
amount of perfusion-weighted contrast
relative to total signal intensity and
the decay of the magnetic label with
blood water T1. For 3.0-T blood water,
T1 is approximately 1600 msec (21);
however, a longer T1 would increase
signal-to-noise ratio and enable spin labeling to be performed for low-velocity
scenarios.
Experiments were performed in
healthy subjects at 3.0 T (n = 6; two
men, four women; mean age, 30 years
6 1). To accurately identify the location
of axillary nodes, a diffusion-weighted
inversion with background suppression
(DWIBS) examination was used (spatial resolution, 3 3 3 3 5 mm; b value,
800 sec/mm2; repetition time msec/
echo time msec/inversion time msec,
8037/49.79/260), which shows high
contrast between lymph nodes and surrounding tissue. For all acquisitions, a
dual-channel (parallel B1) body coil and
a 16-channel torso coil were used for
RF transmission and reception, respectively. Next, a spin labeling approach
with the same section geometry and an
alternating section-selective and nonselective (22) hypersecant 11-msec inversion prepulse was used, followed by
an inversion time range of 500 to 8000
msec in 500-msec increments, to quantify transit time (23). The previously
described pulsed spin labeling approach
was chosen in favor of pseudocontinuous
labeling owing to the low velocity of lymphatic fluid and the difficulty of meeting
flow-driven inversion criteria with high
efficiency (24). A spectral presaturation
with inversion recovery prepulse that
was frequency selective for fat was used
(7.5 msec; bandwidth, 190 Hz) for optimized fat suppression immediately before the RF excitation for section acquisition. Other imaging parameters were
as follows: echo time, 4 msec; spatial
resolution, 3 3 3 3 5 mm; sensitivity
encoding factor, two; half scan factor,
0.6; nine signals acquired; and singleshot gradient-echo echo-planar imaging.
895

TECHNICAL DEVELOPMENTS: Noninvasive Visualization of Lymphatic Flow

Flow-weighted maps were obtained by
subtracting the nonselective inversion
image from the section selective inversion in pairwise fashion (M) and normalizing by equilibrium magnetization
(M0). M0 was calculated by using an inversion recovery image from the longest
inversion time point. The DWIBS image
was used to identify the location of the
axillary lymph nodes for the subsequent
spin labeling experiment. Finally, with
the adiabatic inversion pulse used here,
we experimentally determined that the
RF spillover/spatial tagging inefficiency
was approximately 0.5 mm or 10% of
the section thickness. Thus, the lymph
velocity entering the node is estimated
according to 0.5 mm divided by time to
peak. Reproducibility, interrater variability, and motion were also assessed
and are addressed in Appendixes E1 and
E2 (online).

Spin Labeling Measurements in
Obstructed Lymphatic System
Importantly, the lack of a reference
standard for lymphatic imaging precludes a clear method for validating the
lymphatic spin labeling measurements.
Thus, we performed additional (n = 6)
measurements with known asymmetric
lymphatic impairment. This included
measurements in three healthy subjects (two men and one woman 31, 31,
and 35 years, respectively) with a unilateral blood pressure cuff and clinical
feasibility assessment in three female
patients (aged 60, 43, and 64 years)
with stage II lymphedema secondary to
unilateral breast mastectomy and radiation therapy. The ages of these groups
were not matched, as the purpose of
this experiment was not to specifically
compare groups but rather to demonstrate asymmetric lymphatic velocity
under varying conditions of known
lymphatic impairment. Additionally,
this component of the study was simply to determine if altered lymphatic
flow properties could be detected under conditions of obstructed lymphatic
flow, rather than to provide a detailed
description of the range of lymphatic
obstruction in patients, which would
require additional imaging data. All
patients volunteered to participate in
896
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research by responding to research
flyers posted at a local lymphedema
clinic and were more than 6 months
removed from their most recent radiation treatment. To simulate impaired flow conditions, lymphatic flow
was obstructed in the left arm of the
right-handed healthy subjects by using
a blood pressure cuff, with pressure
maintained at 60 mmHg. Note that as
the cuff was applied unilaterally and all
patients had unilateral lymph node dissection, the contralateral (unaffected)
side was used as an internal control in
all subjects. Diastolic blood pressure in
the healthy subjects ranged from 66 to
75 mmHg, which enabled us to confirm
that venous occlusion would not occur
(7). To allow for reduced flow scenarios
in both the cuffed healthy subjects and
the patients, sampling was performed
over a broader range of potential inflow times (3500–10 000 msec) sampled in 500-msec increments. To reduce the overall examination duration,
the number of signals acquired was
decreased to eight, leading to a total
duration of approximately 40 minutes.
Specifically for the impaired flow study,
data with short labeling delays (500–
1500 msec) were not acquired, since
measuring blood flow was not the intent of these experiments and extending the postlabeling delay range in such
a manner would have added considerably to the total examination time. This
approach enabled us to measure the
longer transit times and slow velocities
of the obstructed lymph within a time
feasible for a study in the clinic.
Since the sample sizes in this feasibility report are small, nonparametric
testing was performed to assess significance of measured velocity differences
in the unaffected versus affected (stage
II lymphedema or cuff-obstructed flow)
arms, as well as in the ratio of the
affected-to-unaffected lymph-to-axilla
velocity of patients versus left-to-right
lymph-to-axilla velocity in healthy subjects. Significance of the measurements
was evaluated by using the Wilcoxon
signed rank test available within the
Matlab software (Mathworks, Natick,
Mass). The criterion for a significant
difference was P , .05.

Results
Relaxation Time Results
Figure 1 shows a representative inversion recovery curve obtained from
a lymphatic fluid sample from which
T1 was calculated, as well as the signal intensity decay of the same sample
as a function of echo time from which
T2 was calculated. Mean T1 and T2
of lymphatic fluid at 3.0 T were found
to be 3100 msec 6 160 (individual
measurements: 3210, 3200, and 2930
msec) and 610 msec 6 12 (individual
measurements, 616 and 598 msec), respectively. When an inversion recovery
acquisition was performed in vivo on a
test subject to null the lymphatic signal
with this T1 value, lymph node signal
was reduced by a factor of 3.3 (nulled
vs not nulled, 6 arbirary units [AU] 6 3
vs 20 AU 6 8) and was not significantly
different (P = .29) from the noise signal
(4 AU 6 2).
Spin Labeling Measurements in
Unobstructed Lymphatic System
Figure 2 shows an example DWIBS
image with a corresponding control
spin labeling image. The lymph nodes,
which were identified on the DWIBS
image, were overlaid on the echoplanar image from the spin labeling
examination for clarity, and free-form
regions of interest in the lymph nodes
(two to four voxels) and a major artery
(three to five voxels) were drawn (S.
Rane, M.J.D.; 7 and 11 years of MR
experience, respectively). An experienced radiologist was consulted to
verify and confirm that the regions of
interest drawn based on the DWIBS
image correctly colocalized with the
lymph nodes. Mean changes in the spin
labeling signal (M/M0) from the blood
and axillary lymph nodes are shown
in Figure 3. In all subjects, contrast in
the blood increases quickly owing to
the fast passage of blood through the
large artery, whereas the curve in the
lymph node rises later owing to the
much slower velocity of lymphatic fluid.
Note that because of the comparatively
short T1 of blood water (approximately
1600–1700 msec at 3.0 T), it was not
possible for this signal change to arise

radiology.rsna.org
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Figure 1

Figure 1: Relaxation time measurements. Graphs of (a) inversion recovery and (b) exponential spin-echo decay of a representative lymphatic fluid sample at 38°C.
Experimental data () and fit (solid line) are shown (Equations 1 and 2, respectively). (c, d) In vivo MR images of lymph nodes (arrows) acquired with (c) DWIBS and
(d) without (left) and with (right) inversion prepulse with echo-planar imaging. Inversion prepulse was placed at the expected null point (inversion time, 1.4 sec; repetition time, 4 sec) of lymphatic water, calculated with T1 of 3100 msec measured from the ex vivo lymphatic sample. (e) Quantitative analysis of signal in the nodes
shows that signal intensity after longitudinal nulling is not significantly different from noise signal. This provides support for the ex vivo T1 measurements reflecting in
vivo lymphatic water T1. Red line represents the median, while the box represents the 25th and 75th percentiles. Error bars indicate the most extreme values in the
data. ∗∗∗ = P , .001.

from blood water. The transit time for
lymph water was 5100 msec 6 970
(median, 5500 msec; range, 3500–
6000 msec), and the time to peak was
5800 msec 6 880 (median, 6250 msec;
range, 4500–6500 msec), which leads
to a calculated lymphatic fluid velocity
at the level of the afferent vessel entering the node of 0.61 cm/min 6 0.13
Radiology: Volume 269: Number 3—December 2013
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(median, 0.57 cm/min; range, 0.5–0.85
cm/min).

Spin Labeling Measurements in
Obstructed Lymphatic System
There was a reduction in lymphatic
flow velocity in the affected (mean,
0.48 cm/min 6 0.15; median, 0.46
cm/min; range, 0.33–0.66 cm/min)

radiology.rsna.org

versus unaffected (mean, 0.61 cm/min
6 0.22; median, 0.58 cm/min; range,
0.35–0.85 cm/min) arms of patients
with stage II lymphedema (P = .06) and
in the affected (mean, 0.47 cm/min 6
0.14; median, 0.46 cm/min; range,
0.31–0.66 cm/min) versus unaffected
(mean, 0.58 cm/min 6 0.16; median,
0.66 cm/min; range, 0.35–0.75 cm/
897
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Figure 2

Figure 2: Lymph node identification. (a–c) Representative DWIBS MR images
in a 30-year-old male patient clearly show the lymph nodes across orthogonal
axes within the white rectangles. A typical axial section (c) along the white line
in a is used to guide the section location for spin labeling. (d) Corresponding
spin labeling MR image in a control subject. Location and planning were guided
by DWIBS contrast. (e) DWIBS MR image overlaid on d and thresholded to
identify different structures (green = cerebrospinal fluid, yellow = lymph, red
= outline of cardiac tissue and major blood vessels) and to draw the regions of
interest (two to four voxels) to evaluate lymph kinetic curves.

min) arms of healthy subjects (P =
.12) with unilateral flow stenoocclusion
when a pressure cuff was used (Fig 4).
When the groups of three subjects
were compared for asymmetric delay
in lymphatic velocity, the differences
were not significant (P = .06–.12); however, they became significant (P = .004)
when the two groups were considered
together (Fig 4b). Unaffected-to-affected ratio was 1.27 6 0.18 in patients
with stage II lymphedema and 1.21
6 0.18 in healthy subjects with cuffobstructed flow; left-to-right ratio was
0.91 6 0.08 in healthy subjects with
unobstructed flow.
898

Discussion
The overall finding of this work is that
long T1 of lymphatic water enables us
to estimate lymphatic velocity with spin
labeling methods. Clinical feasibility of
this approach is also demonstrated in
patients with lymphatic flow obstruction.
Our measurements of T1 and T2
values for human lymph at 3.0 T should
be useful to generate optimized lymphatic MR imaging contrast. These measurements have not been performed in

the past because of the difficulty of isolating the pure lymphatic voxels in vivo
and the pure lymphatic fluid samples ex
vivo. Similar to blood water T1, which
varies with oxygenation and hematocrit level, lymphatic T1 will vary with
location, protein content, and disease
severity. The ex vivo T1 measurement
was approximately correct in in vivo Mz
nulling experiments. Finally, it should
be noted that blood water additionally
varies with oxygenation, vessel size,
and hematocrit level; thus, the success

radiology.rsna.org
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Figure 3

Figure 3: Unobstructed lymphatic flow results. Lymphatic and blood water magnetization as a function of
postlabeling delay times in six separate healthy subjects. In-plane dimensions of lymph nodes evaluated for
each subject are also reported. Note that blood signal increases quickly owing to the short T1 of blood water
and fast blood water velocity. Alternatively, signal in the axillary lymph node increases much later, because of
the much slower velocity of lymph fluid. The relatively rapid rise and fall of the lymphatic curve is consistent
with mixing of lymphatic water in the node and finite node dwell times, similar to the macrovascular blood
compartment in arterial spin labeling experiments (Appendix E3 [online]). F = female, M = male, ROI =
region of interest.

of arterial spin labeling may be interpreted as an exemplar for why small
variations in lymphatic T1 may not be
an overwhelming confounding variable.
In the context of literature values,
the velocity measured in our study
is slower than that in most studies
that measured large-vessel velocity.
Radiology: Volume 269: Number 3—December 2013
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Importantly, to phagocytose and filter
detrimental substances, lymph flow into
the intranodal sinus system is much
slower than in large vessels populated
with lymphangions (25). Additionally,
as lymph circulates through multiple
nodes, it becomes denser and reduces
velocity. By using technetium 99m

radiology.rsna.org
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human immunoglobulin G, Modi et al
(7) found a relatively large mean handto–axillary node velocity of 8.9 cm/
min 6 5.8, with a transit time of 9.6
minutes 6 7.2. By using fluorescence
video microscopy in the foot, Fischer et
al (26) showed that the median resting
capillary velocity was 0.058 cm/min in
the human skin. With fluorescence recovery after photobleaching in a mouse
model, Berk et al (27), and Swartz et
al (28) found the velocity to be 0.028
cm/min and 0.018–0.024 cm/min, respectively. Most studies are performed
in superficial lymphatic vessels and are
performed over short distances with invasive dyes that change vessel pressure
and skin lymphatic activity. The mean
entry velocity measured here (0.61
cm/min) is on the lower end of the
reported velocity ranges for large and
small vessels, as expected for the location of the measurement. Other MR
approaches have also been used with
some success to detect lymph nodes
and evaluate lymphatic flow by using
ultrasmall superparamagnetic iron oxide and gadolinium chelates, albeit
with low sensitivity (6). A study (29)
to assess the reproducibility, reliability,
and accuracy of unenhanced MR imaging methods, specifically T1-weighted
imaging and diffusion-weighted imaging (30), in metastatic lymph nodes in
patients with breast cancer concluded
that these methods are not yet ready
for clinical implementation. However,
promising work in animals has shown
that very-low-dose gadolinium-conjugated dendrimers, which have been
used successfully in pigs, potentially
could be used in humans (31).
Our findings in controlled pressure
cuff scenarios in healthy subjects and
patients with intermediate-stage (stage
II) lymphedema showed reduced lymphatic velocity in the affected arm. The
number of subjects who were studied
for obstructed lymph flow measurements was low, since the primary purpose of the study was to assess feasibility. The lymphatic velocity, although
frequently reduced, showed a trend
for a significant reduction in the affected versus unaffected arms in both
groups. Importantly, combining the two
899
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Figure 4

Figure 4: Obstructed lymphatic flow results. (a) Lymphatic flow
curves for a representative healthy 31-year-old male volunteer
with unilateral cuff steno-occlusion of lymphatic fluid (pressure,
60 mmHg) (top) and for a 60-year-old female patient with stage
II lymphedema secondary to unilateral breast cancer mastectomy
(bottom). In healthy subjects and patients, a delay in lymphatic
arrival times on the affected side relative to the unaffected side is
observed. Additionally, multiple arrival times are found, consistent
with multiple afferent vessels delivering lymphatic water to the node.
(b) Ratio of lymphatic flow velocity in the unaffected arm to that in
the affected arm was significantly higher (1.24 6 0.18, P , .005)
in the six impaired subjects when compared with lymphatic velocity
ratio in the left arm to that in the right arm in healthy subjects shown
in Figure 3 (0.9124 6 0.08). Red line represents the median, while
the box represents the 25th and 75th percentiles. Error bars indicate
the extreme values measured in this data. Dashed line represents
the line of unity indicating identical lymph velocity in both arms. ∗∗
= P , .005.

populations resulted in a significant (P
, .005) decrease in lymphatic velocity
on the impaired side when compared
with the unimpaired side. Furthermore, the ratio of lymphatic velocity in
the unaffected arm to lymphatic velocity in the affected arm is significantly
(P , .005) greater than the ratio of
lymphatic flow velocities in both arms
in healthy subjects, which is approximately one, indicating identical lymph
flow in the healthy left and right arms.
This outcome supports the idea that the
lymphatic spin labeling technique can
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be used to detect clinical differences in
lymphatic flow velocity.
Additionally, it should be noted that
the rise and fall of the lymphatic spin labeling kinetic curve is much sharper than
that of the perfusion kinetic curve. We
have outlined a kinetic model justifying
this response in Appendix E3 (online)
and believe that this effect occurs because the lymphatic system more closely
reflects the macrovascular compartment
of arterial spin labeling models, with the
addition of mixing within the node and
an extended dwell time.

Several limitations of this study
should be considered. First, our approach measures lymph flow into the
nodes and does not discriminate between how many nodes the fluid has
traversed, which will influence viscosity
and velocity. However, in cases of obstructed flow, we did observe differences
in affected versus unaffected arms, lending support to the clinical potential of
this technique. Lymphatic velocity will
likely be much slower in patients with
lymphedema, causing the spin labeling
curves to shift further to the right. This
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may cause the lymphatic water label to
decay before it enters the node. However, the T1 of lymphatic water is very
long at 3.0 T (3100 msec). Thus, for
efficient RF inversion pulses, longitudinal magnetization will be reduced from
equilibrium by approximately 29% (at a
time to peak of 6000 msec) to approximately 8% (at a time to peak of 10 000
msec). Efficient spin labeling does allow
for flow estimation over a large timeto-peak range, as shown in the clinical
feasibility test. Multisection approaches
could be implemented, enabling lymph
flow measurements over a larger spatial domain. Finally, signal-to-noise ratio
can be increased through background
suppression pulses, whereby the static
signal within a section is suppressed by
using principles of inversion recovery
(32). Background suppression, in potential combination with other spin labeling
improvement variants, such as magnetization transfer, steady-state free precession, or diffusion gradients, may additionally help better identify lymphatic
vessels from surrounding tissue (18,33).
In conclusion, we have shown that
owing to the long T1 of lymphatic
fluid, principles of spin labeling can be
extended to measure lymphatic flow
in healthy subjects and patients with
lymphedema. This approach is noninvasive, can be performed with clinically
available MR imaging equipment, and
holds potential in the identification of
patients at highest risk for lymphedema
related to breast cancer treatment or in
the evaluation of response of the lymphatic system to novel therapies.
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